Major Shareholding Notification • May 11, 2015
Major Shareholding Notification
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 7754M
Silence Therapeutics PLC
11 May 2015
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Silence Therapeutics Plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | Dilution due to additional placing of shares | X | ||
| 3. Full name of person(s) subject to the notification obligation: |
Richard Griffiths and controlled undertakings | |||
| 4. Full name of shareholder(s) (if different from 3.): | ||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: |
8 May 2015 | |||
| 6. Date on which issuer notified: | 11 May 2015 | |||
| 7. Threshold(s) that is/are crossed or reached: |
24, 23, 22, 21% | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights | ||||||||||||
| Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
| GB00B9GTXM62 | 13,017,176 | 13,017,176 | 14,409,248 | 14,409,248 | 20.64% | |||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted |
% of voting rights |
||||||||||||
| CFD | 226,000 | 0.32% | ||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date | Exercise/ Conversion period |
Number of voting rights instrument refers to | % of voting rights xix, | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 14,409,248 | 20.97% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
| Cream Capital Limited | 599,033 |
| Blake Holdings Limited | 6,697,071 |
| Seren Capital Management Limited | 5,657,974 |
| Richard Griffiths direct holdings | 566,180 |
| Richard Griffiths indirect holdings | 692,153 |
| Oak Trust Limited | 196,837 |
| 14,409,248 | |
| CFD | 226,000 |
| Total | 14,635,248 |
The above undertakings are all controlled by Richard Griffiths
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
James Sutcliffe
15. Contact telephone number:
01534 719 761
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAURRVKAVAAR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.